Company Overview of Nektar Therapeutics
Independent Director and Chairman of Organization & Compensation Committee, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 2 Board Members in 2 different organizations across 6 different industries.|
See Board Relationships
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships
Independent Director and Chairman of Organization & Compensation Committee
EducationThere is no Education data available.
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|Michael W. Aguiar||Chief Executive Officer, President, Director and Member of Stock Option Committee|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science Committee|
Progenics Pharmaceuticals, Inc.
|Peter S. Greenleaf||Chairman and Chief Executive Officer|
Sucampo Pharmaceuticals, Inc.
|$565.3K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.